A detailed history of Pfs Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Pfs Partners, LLC holds 4 shares of NVO stock, worth $354. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4
Previous 4 -0.0%
Holding current value
$354
Previous $571,000 16.46%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 26, 2024

SELL
$87.78 - $105.45 $526 - $632
-6 Reduced 60.0%
4 $414,000
Q3 2023

Nov 30, 2023

BUY
$90.94 - $199.54 $454 - $997
5 Added 100.0%
10 $915,000
Q1 2023

Nov 30, 2023

BUY
$132.34 - $159.14 $661 - $795
5 New
5 $796,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $200B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Pfs Partners, LLC Portfolio

Follow Pfs Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfs Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pfs Partners, LLC with notifications on news.